Bank Of America Corp Supernus Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 405,601 shares of SUPN stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

405,601

Previous 360,599 12.48%

Holding current value

$14.8 Million

Previous $12.3 Million 11.8%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $1.17 Million - $1.52 Million	45,002 Added 12.48%	405,601 $10.8 Million
Q1 2024 May 15, 2024	SELL	$27.11 - $35.17 $110,581 - $143,458	-4,079 Reduced 1.12%	360,599 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $1.41 Million - $1.84 Million	62,001 Added 20.48%	364,678 $10.6 Million
Q2 2023 Aug 14, 2023	SELL	$29.91 - $38.73 $1.06 Million - $1.37 Million	-35,491 Reduced 10.5%	302,677 $9.1 Million
Q1 2023 May 12, 2023	BUY	$34.93 - $42.03 $46,910 - $56,446	1,343 Added 0.4%	338,168 $12.3 Million
Q4 2022 Feb 10, 2023	BUY	$31.09 - $37.88 $53,847 - $65,608	1,732 Added 0.52%	336,825 $12 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $349,740 - $430,160	12,148 Added 3.76%	335,093 $11.3 Million
Q2 2022 Aug 12, 2022	SELL	$25.33 - $34.25 $4.59 Million - $6.21 Million	-181,228 Reduced 35.95%	322,945 $9.34 Million
Q1 2022 May 16, 2022	SELL	$28.51 - $32.9 $876,568 - $1.01 Million	-30,746 Reduced 5.75%	504,173 $16.3 Million
Q4 2021 Feb 08, 2022	BUY	$26.37 - $34.22 $1.39 Million - $1.8 Million	52,661 Added 10.92%	534,919 $15.6 Million
Q3 2021 Nov 15, 2021	SELL	$23.54 - $31.39 $2.35 Million - $3.13 Million	-99,793 Reduced 17.15%	482,258 $12.9 Million
Q2 2021 Sep 13, 2021	BUY	$26.72 - $33.19 $15.6 Million - $19.3 Million	582,051 New	582,051 $17.9 Million

Others Institutions Holding SUPN

# of Institutions

267

Shares Held

59.7M

Call Options Held

47.9K

Put Options Held

13.1K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.96B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Supernus Pharmaceuticals, Inc. Transaction History